卵巢癌化疗患者消化道症状群管理的最佳证据总结

doi:10.3761/j.issn.2096-7446.2023.11.016

摘要/Abstract

摘要： 目的检索、评价并整合卵巢癌化疗患者消化道症状群管理的最佳证据。方法根据“6S”模型,系统检索相关中英文数据库和网站中有关卵巢癌化疗患者消化道症状群管理的文献,包括临床决策、指南、专家共识、证据总结及系统评价,检索时限为2013年1月—2023年3月。结果共纳入18篇文献,其中临床决策2篇、指南5篇、专家共识4篇、证据总结2篇、系统评价5篇。从恶心与呕吐、腹泻、口腔黏膜炎、食欲下降和味觉改变的管理及多学科团队5个方面总结出28条证据。结论该研究总结的卵巢癌化疗患者消化道症状群管理的最佳证据,可为临床实践提供循证依据,医护人员可在此基础上根据患者的实际症状和需求,制订个性化的护理管理方案。

关键词: 卵巢癌, 化疗, 消化系统, 症状和体征, 肿瘤护理, 循证护理学

Abstract: Objective To search,evaluate,and summarize the best evidence for the management of digestive tract symptom group in patients with ovarian cancer undergoing chemotherapy. Methods According to the "6S" model,this study systematically searched the literatures related to the management of digestive tract symptoms in patients with ovarian cancer undergoing chemotherapy in domestic and foreign databases and websites,including clinical decision-making,guidelines,expert consensuses,evidence summaries and systematic reviews. The retrieval time was from January 2013 to March 2023. Results 18 articles were included,including 2 clinical decisions,5 guidelines,4 expert consensuses,2 evidence summaries and 5 systematic reviews. Twenty-eight pieces of evidence were summarized from five aspects：management of nausea and vomiting,management of diarrhea,management of oral mucositis,management of loss of appetite and taste change,and multidisciplinary teams. Conclusion The best evidence of digestive tract symptom group management of patients with ovarian cancer undergoing chemotherapy summarized in this study can provide an evidence-based basis for clinical practice,and medical staff can make personalized nursing management plans according to the actual symptoms and needs of patients.

Key words: Ovarian Cancer, Chemotherapy, Digestive System, Symptoms and Signs, Tumor Care, Evidence-based Nursing

孟玉玲, 项珍珍, 冯姣姣, 陈亚芳, 张乐, 冯素文. 卵巢癌化疗患者消化道症状群管理的最佳证据总结[J]. 中华急危重症护理杂志, 2023, 4(11): 1037-1044.

MENG Yuling, XIANG Zhenzhen, FENG Jiaojiao, CHEN Yafang, ZHANG Le, FENG Suwen. Summary of the best evidence of digestive tract symptom group management in patients with ovarian cancer undergoing chemotherapy[J]. Chinese Journal of Emergency and Critical Care Nursing, 2023, 4(11): 1037-1044.

参考文献

[1] Siegel R,Ma JM,Zou ZH,et al.Cancer statistics,2014[J]. CA Cancer J Clin,2014,64(1):9-29.
[2] 中国抗癌协会妇科肿瘤专业委员会. 卵巢恶性肿瘤诊断与治疗指南(2021年版)[J]. 中国癌症杂志,2021,31(6):490-500.
Chinese Anti-Cancer Association Gynecological Tumor Profes-sional Committee. Guidelines for diagnosis and treatment of ovarian malignant tumors(2021 edition)[J]. China Oncol,2021,31(6):490-500.
[3] 曹冬焱. 卵巢癌规范化诊疗与进展[J]. 中国临床医生杂志,2023,51(3):268-271.
Cao DY.Standardized diagnosis and treatment of ovarian cancer and its progress[J]. Chin J Clin,2023,51(3):268-271.
[4] Li G.A review of the research on symptom clusters in cancer survivors[J]. Open J Nurs,2021,11(6):423-434.
[5] Orr B,Edwards RP.Diagnosis and treatment of ovarian cancer[J]. Hematol Oncol Clin North Am,2018,32(6):943-964.
[6] Lobach DF,Johns EB,Halpenny B,et al.Increasing complexity in rule-based clinical decision support:the symptom assessment and management intervention[J]. JMIR Med Inform,2016,4(4):e36.
[7] 胡雁,郝玉芳. 循证护理学[M]. 2版. 北京:人民卫生出版社,2018.
Hu Y,Hao YF.Evidence-based nursing[M]. 2nd ed. Beijing:People's Medical Publishing House,2018.
[8] 王春青,胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志,2015,30(11):964-967.
Wang CQ,Hu Y.JBI evidence pre-classification and evidence recommendation level system(2014 edition)[J]. J Nurses Train,2015,30(11):964-967.
[9] Hesketh PJ. Prevention-of-chemotherapy-induced-nausea-and-vomiting-in-adults[EB/OL]. (2023-03-24)[2023-05-03].https://www.uptodate.cn/contents/zh-Hans/prevention-of-chemotherapy-induced-nausea-and-vomiting-in-adults.
[10] Krishnamurthi SS. Management-of-acute-chemotherapy-related-di-arrhea[EB/OL]. (2023-03-01)[2023-05-03]. https://www.uptodate.cn/contents/zh-Hans/management-of-acute-chemotherapy-rela-ted-diarrhea.
[11] Armstrong DK,Alvarez RD,Backes FJ,et al. Ovarian cancer,Version 1.2023,NCCN clinical practice guidelines in oncology[EB/OL].(2022-12-22)[2023-05-03]. https://www.nccn.org/gui-delines.
[12] Dans M,Walling AM,Agarwal R,et al. Palliative care,Version 1.2023,NCCN clinical practice guidelines in oncology[EB/OL]. (2023-01-30)[2023-05-03].https://www.nccn.org/guidelines.
[13] Ettinger DS,Berger MJ,Agarwal R,et al. Antiemesis,Version 1.2023,NCCN clinical practice guidelines in oncology[EB/OL]. (2023-01-25)[2023-05-03]. https://www.nccn.org/guidelines.
[14] Elad S,Cheng KKF,Lalla RV,et al.MASCC/ISOO clinical prac-tice guidelines for the management of mucositis secondary to cancer therapy[J]. Cancer,2020,126(19):4423-4431.
[15] 中国抗癌协会妇科肿瘤专业委员会. 中国卵巢上皮性癌维持治疗指南(2022年版)[J]. 中国实用妇科与产科杂志,2022,38(1):56-65.
Chinese Anti-Cancer Association Gynecological Tumor Professional Committee. Guidelines for maintenance treatment of epithelial ovarian cancer in China(2022 edition)[J]. Chin J Pract Gynecol Obstet,2022,38(1):56-65.
[16] 中国抗癌协会肿瘤营养专业委员会,全国卫生产业企业管理协会医学营养产业分会,浙江省医学会肿瘤营养与治疗学分会. 肿瘤患者食欲下降的营养诊疗专家共识[J]. 肿瘤代谢与营养电子杂志,2022,9(3):312-319.
Cancer Nutrition Committee of Chinese Anti-Cancer Associa-tion,Medical Nutrition Industry Branch of National Health Industry Enterprise Management Association,Cancer Nutrition and Therapeutics Branch of Zhejiang Medical Association. Expert consensus on the nutritional diagnosis and treatment of appetite loss in cancer patients[J]. Electron Jourmal Metab Nutr Cancer,2022,9(3):312-319.
[17] 中国抗癌协会妇科肿瘤专业委员会. PARP抑制剂不良反应管理的中国专家共识(2021年版)[J]. 中国实用妇科与产科杂志,2021,37(11):1119-1130.
Chinese Anti-Cancer Association Gynecological Tumor Professional Committee. China expert consensus on adverse drug reaction management of PARP inhibitors(2021 edition)[J]. Chin J Pract Gynecol Obstet,2021,37(11):1119-1130.
[18] 中国抗癌协会肿瘤营养专业委员会. 卵巢癌患者的营养治疗专家共识[J]. 肿瘤代谢与营养电子杂志,2020,7(4):418-420.
Cancer Nutrition Committee of Chinese Anti-Cancer Associa-tion. Expert consensus on nutritional therapy for patients with ovarian cancer[J]. Electron J Metab Nutr Cancer,2020,7(4):418-420.
[19] 上海市抗癌协会癌症康复与姑息专业委员会. 化疗所致恶心呕吐全程管理上海专家共识(2018年版)[J]. 中国癌症杂志,2018,28(12):946-960.
Shanghai Anti-Cancer Association Cancer Rehabilitation and Palliative Professional Committee. Shanghai expert consensus on the whole course management of chemotherapy-induced nausea and vomiting(2018 edition)[J]. China Oncol,2018,28(12):946-960.
[20] Li KX,Cai YY,Xie S,et al.Evidence summary for nonphar-macological management of chemotherapy-induced nausea and vomiting[J]. Biomed Res Int,2022,2022:4741193.
[21] 宋继红,王涛,王玉洁,等. 成人肿瘤患者放化疗期间癌因性疲乏运动干预的最佳证据总结[J]. 中国康复医学杂志,2022,37(9):1289-1295.
Song JH,Wang T,Wang YJ,et al.Summary of the best evidence of exercise intervention for cancer-related fatigue in adult tumor patients during radiotherapy and chemotherapy[J]. Chin J Rehabil Med,2022,37(9):1289-1295.
[22] Mozaffar B,Ardavani A,Muzafar H,et al.The effectiveness of zinc supplementation in taste disorder treatment:a systematic review and meta-analysis of randomized controlled trials[J]. J Nutr Metab,2023,2023:6711071.
[23] Buttiron Webber T,Briata IM,DeCensi A,et al. Taste and smell disorders in cancer treatment:results from an integrative rapid systematic review[J]. Int J Mol Sci,2023,24(3):2538.
[24] Feng J,Gao M,Zhao CC,et al.Oral administration of probiotics reduces chemotherapy-induced diarrhea and oral mucositis:a systematic review and meta-analysis[J]. Front Nutr,2022,9:823288.
[25] Brown TJ,Gupta A.Management of cancer therapy-associated oral mucositis[J]. JCO Oncol Pract,2020,16(3):103-109.
[26] Tian X,Tang RY,Xu LL,et al.Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients:a systematic review of six randomized controlled trials[J]. Support Care Cancer,2020,28(9):4051-4058.
[27] Hu ZH,Liang WH,Yang YP,et al.Personalized estimate of chemotherapy-induced nausea and vomiting:development and external validation of a nomogram in cancer patients receiv-ing highly/moderately emetogenic chemotherapy[J]. Medicine(Baltimore),2016,95(2):e2476.
[28] Pulito C,Cristaudo A,Porta C,et al.Oral mucositis:the hidden side of cancer therapy[J]. J Exp Clin Cancer Res,2020,39(1):210.
[29] Kiss N,Symons K,Hewitt J,et al.Taste function in adults undergoing cancer radiotherapy or chemotherapy,and implications for nutrition management:a systematic review[J]. J Acad Nutr Diet,2021,121(2):278-304.
[30] Braud A,Boucher Y.Taste disorder's management:a systematic review[J]. Clin Oral Investig,2020,24(6):1889-1908.